- Home
- ENLV vs HUIZ Comparison
ENLV vs HUIZ Comparison
Compare ENLV & HUIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENLV
- HUIZ
- Stock Information
- Founded
- ENLV 2005
- HUIZ 2006
- Country
- ENLV Israel
- HUIZ China
- Employees
- ENLV N/A
- HUIZ N/A
- Industry
- ENLV Biotechnology: Pharmaceutical Preparations
- HUIZ Specialty Insurers
- Sector
- ENLV Health Care
- HUIZ Finance
- Exchange
- ENLV Nasdaq
- HUIZ Nasdaq
- Market Cap
- ENLV 25.5M
- HUIZ 25.3M
- IPO Year
- ENLV 1995
- HUIZ 2020
- Fundamental
- Price
- ENLV $1.05
- HUIZ $3.06
- Analyst Decision
- ENLV Strong Buy
- HUIZ Hold
- Analyst Count
- ENLV 2
- HUIZ 1
- Target Price
- ENLV $10.00
- HUIZ $2.30
- AVG Volume (30 Days)
- ENLV 355.7K
- HUIZ 721.2K
- Earning Date
- ENLV 08-29-2025
- HUIZ 09-12-2025
- Dividend Yield
- ENLV N/A
- HUIZ N/A
- EPS Growth
- ENLV N/A
- HUIZ N/A
- EPS
- ENLV N/A
- HUIZ 0.25
- Revenue
- ENLV N/A
- HUIZ $186,519,166.00
- Revenue This Year
- ENLV N/A
- HUIZ $11.94
- Revenue Next Year
- ENLV N/A
- HUIZ $8.15
- P/E Ratio
- ENLV N/A
- HUIZ $15.34
- Revenue Growth
- ENLV N/A
- HUIZ 19.12
- 52 Week Low
- ENLV $0.81
- HUIZ $1.50
- 52 Week High
- ENLV $2.10
- HUIZ $10.58
- Technical
- Relative Strength Index (RSI)
- ENLV 42.04
- HUIZ 53.66
- Support Level
- ENLV $1.00
- HUIZ $2.70
- Resistance Level
- ENLV $1.08
- HUIZ $4.53
- Average True Range (ATR)
- ENLV 0.04
- HUIZ 0.30
- MACD
- ENLV 0.01
- HUIZ 0.09
- Stochastic Oscillator
- ENLV 50.00
- HUIZ 28.99
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.